Fibromyalgia

Ketamine and fibromyalgia: what off-label means, and what is still unknown

If you have lived with fibromyalgia for a few years, ketamine has probably crossed your screen by now: a thread in a support group, a cousin's post, a clinic billboard on I-64 that promises a lot in very few words. Most of the women who ask about it are somewhere between their late thirties and their mid fifties, holding a job and a household together while their body hurts in ways no scan shows. What follows is written for you, and it walks through what off-label means, what the research does and does not say, and why ketamine for pain is a different thing from the depression treatment called Spravato.

What off-label actually means

Every prescription drug sold in the United States carries official labeling that lists the uses it was studied for and cleared for. A doctor may still prescribe it for something outside that list when, in their judgment, it makes sense for a particular patient. That is off-label prescribing. It is legal and common across medicine, from pediatrics to cancer care.

Ketamine was developed as an anesthetic, and anesthesia is what its labeling covers. When ketamine is given for fibromyalgia pain, that use is off-label. The phrase does not mean reckless, and it does not mean proven. It means the decision rests on one prescriber's judgment and on a thinner body of evidence than a labeled use would have behind it. In practice it also tends to mean your insurance plan will not pay, so the bill lands on you.

What the research says so far

Researchers became interested in ketamine for long-lasting pain because it blocks NMDA receptors, part of the machinery the nervous system uses to turn pain signals up. Fibromyalgia is widely thought to involve that kind of turned-up signaling, often called central sensitization, so the idea has a reasonable starting point.

The studies themselves are small, short and mixed. Some reported that pain eased during or soon after an infusion and then drifted back. Others found little difference from a placebo. Doses, schedules and the ways researchers measured pain vary so much that the trials are hard to line up against each other. There is no agreed protocol for fibromyalgia, and little is known about what repeated sessions over months or years do. The fair summary is that the evidence is limited, and a clinic that sounds certain is ahead of the science.

For the basics of the condition itself, the National Institute of Arthritis and Musculoskeletal and Skin Diseases keeps a plain overview of fibromyalgia, its symptoms and its usual treatments. It is worth a read before any appointment where a new option will come up.

Ketamine for pain is not Spravato

Here is where a lot of confusion starts. Spravato is a nasal spray made from esketamine, one of the two mirror-image forms that together make up ketamine. The FDA approved it for two kinds of depression in adults: depression that stayed put through two or more antidepressant trials, and major depression that comes with suicidal thoughts or actions. It is given only in certified clinics, under a safety program, with at least two hours of monitoring afterward, and the patient never takes it home.

So Spravato is a depression treatment. It is not a pain treatment, and a clinic offering it is treating depression. Ketamine given through an IV for pain is a different product, a different route and a separate, off-label decision. If a conversation blurs the two, ask which one is actually on the table.

Why the depression question still matters

Fibromyalgia and depression show up together often enough that many rheumatologists ask about mood at every visit. Pain that other people cannot see wears a person down, and depression, in turn, can make pain feel louder and sleep thinner. If two or more antidepressants have come and gone and the heaviness, flatness or hopelessness has not lifted, that is a depression question in its own right. It deserves its own evaluation, apart from your pain plan.

That is the lane where Brain Recovery Centers works. Its focus is depression that has outlasted the usual first and second tries, including Brain Recovery Centers, not pain management, so your fibromyalgia care stays with the doctors who already know you. The clinic offers a free 30-minute consultation in person at either of its two locations: Chesterfield, at 18118 Chesterfield Airport Road, Suite G, and South County, at 3934 Union Rd in St. Louis. It does not sell medication and does not see patients by telemedicine.

Questions to bring to any clinic

• Is this treatment meant for my pain, my depression, or both, and what is the evidence for each one?
• Is this use on-label or off-label, and what will my plan cover?
• Who watches me during and after a session, and how will notes reach my rheumatologist or primary care doctor?
• How will we decide whether it is helping, and what happens if it is not?
• How does it fit with what I already take for pain, sleep or mood?

A careful clinic welcomes those questions. Be wary of any answer that comes with a number promising how many patients feel better.

Keep your own doctors at the center

Fibromyalgia care is usually multimodal: regular, gentle movement, steady attention to sleep, talk therapy approaches such as cognitive behavioral therapy, and medicines chosen for your situation. No single treatment replaces that plan. If ketamine ever belongs in it, it would be one piece, decided with the doctors who manage your pain. The large systems around St. Louis, including BJC, Mercy and SSM Health, all run rheumatology practices, and a primary care doctor can refer you if you do not have a rheumatologist yet.

If your mood ever turns toward thoughts of ending your life, the Suicide and Crisis Lifeline answers calls and texts at 988, every hour of every day.

Educational content only. Nothing here is medical advice for you personally; decisions about ketamine or any other treatment belong with your own clinicians.